Stay updated on Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.

Latest updates to the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded a site-wide government funding status notice and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check11 days agoChange DetectedGlossary display added; minor labeling and revision metadata updates were implemented. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe update shows a new revision label (v3.3.4) replacing the previous v3.3.3. No study data or essential details appear to be changed.SummaryDifference0.0%

- Check46 days agoChange DetectedExpanded the Locations section to include sites across Arizona, California, Connecticut, Florida, Illinois, Maryland, Minnesota, Missouri, Nevada, New Mexico, New York, Ohio, Oklahoma, Oregon, Tennessee, Texas, and Virginia, and noted Revision: v3.3.3.SummaryDifference1%

- Check75 days agoChange DetectedThe Publications section now states entries are auto-filled from PubMed and may not relate to the study, and the revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check82 days agoChange DetectedRemoval of the site-wide notice about government funding and NIH operating status is reflected on the page, with no impact on study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.